# A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

> **NCT00476424** · PHASE2 · COMPLETED · sponsor: **The HIV Netherlands Australia Thailand Research Collaboration** · enrollment: 28 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** efavirenz

## Key facts

- **NCT ID:** NCT00476424
- **Lead sponsor:** The HIV Netherlands Australia Thailand Research Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476424, "A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00476424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*